All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Comparative Pathology

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jcpa.2012.11.232PMID 23276382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD25 Is Expressed by Canine Cutaneous Mast Cell Tumors but not by Cutaneous Connective Tissue Mast Cells

  2012cited by this paper
• Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes

  2012cited by this paper
• Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological Behavior

  2011cited by this paper
• Excavation of a buried treasure--DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues.

  2011cited by this paper
• Role of immunotherapy for renal cell cancer in 2011.

  2011cited by this paper
• Efficient and Cost-Effective Extraction of Genomic DNA From Formalin-Fixed and Paraffin-Embedded Tissues

  2011cited by this paper
• Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates.

  2011cited by this paper
• The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.

  2011cited by this paper
• Intra‐lesional interleukin‐2 for the treatment of in‐transit melanoma

  2011cited by this paper
• Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

  2010cited by this paper
• The Combined Expression Pattern of BMP2, LTBP4, and DERL1 Discriminates Malignant From Benign Canine Mammary Tumors

  2010cited by this paper
• Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.

  2010cited by this paper
• Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factor.

  2010cited by this paper
• Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.

  2009cited by this paper
• Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.

  2009cited by this paper
• IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.

  2009cited by this paper
• Immunophenotyping of mast cells: a sensitive and specific diagnostic tool for systemic mastocytosis.

  2009cited by this paper
• Increased Expression of BRCA2 and RAD51 in Lymph Node Metastases of Canine Mammary Adenocarcinomas

  2009cited by this paper
• IL-2 and its high-affinity receptor: genetic control of immunoregulation and autoimmunity.

  2009cited by this paper
• The biology of interleukin-2.

  2008cited by this paper
• Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix.

  2008cited by this paper
• Interleukin-2 receptor downstream events in regulatory T cells: Implications for the choice of immunosuppressive drug therapy

  2008cited by this paper
• Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497

  2007cited by this paper
• Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.

  2007cited by this paper
• The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

  2006cited by this paper
• Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia

  2006cited by this paper
• Both integrated and differential regulation of components of the IL-2/IL-2 receptor system.

  2006cited by this paper
• Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.

  2004cited by this paper
• Detection of c-kit Mutations in Canine Mast Cell Tumors using Fluorescent Polyacrylamide Gel Electrophoresis

  2004cited by this paper
• Interleukin-2 and its receptor complex (α, β and γ chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study

  2003cited by this paper
• Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

  2001cited by this paper
• Functional IL-2 Receptor β (CD122) and γ (CD132) Chains Are Expressed by Fibroblast-Like Synoviocytes: Activation by IL-2 Stimulates Monocyte Chemoattractant Protein-1 Production1

  2001cited by this paper
• Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression

  2000cited by this paper
• Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.

  2000cited by this paper
• The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines

  1999cited by this paper
• Molecular analysis of the IL-2 receptor β chain gene expressed in human tumor cells

  1998cited by this paper
• Endogenous IL-2 in Cancer Cells: A Marker of Cellular Proliferation

  1998cited by this paper
• Evidence for the participation of interleukin-2 (IL-2) and IL-4 in the regulation of autonomous growth and tumorigenesis of transformed cells of lymphoid origin.

  1997cited by this paper
• B16F10 murine melanoma cells express interleukin-2 and a functional interleukin-2 receptor.

  1996cited by this paper
• Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.

  1995cited by this paper
• Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling

  1994cited by this paper
• Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling.

  1994cited by this paper
• Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15.

  1994cited by this paper
• Human melanoma cell line M14 secretes a functional interleukin 2.

  1993cited by this paper
• Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4.

  1993cited by this paper
• Cloning of the gamma chain of the human IL-2 receptor.

  1992cited by this paper
• Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions.

  1986cited by this paper
• Canine Cutaneous Mast Cell Tumor: Morphologic Grading and Survival Time in 83 Dogs

  1984cited by this paper
• Molecular cloning and expression of cDNAs for the human interleukin-2 receptor

  1984cited by this paper

• Evaluation serum soluble interleukin 2 receptor with diagnosis and prognosis in canine solid tumour: 34 cases

  2024cites this paper
• Expression of genes encoding interleukin 15 and its receptor subunits in the duodenal and colonic mucosae of dogs with chronic enteropathy

  2022cites this paper
• Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal

  2021cites this paper
• Novel Prognostic and Predictive Markers for Canine Mast Cell Tumours

  2019cites this paper
• Grundprinzipien der Tumorstehung

  2017cites this paper
• Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome

  2016cites this paper
• Basic Principles of Carcinogenesis

  2016cites this paper
• C-kit as a prognostic and therapeutic marker in canine cutaneous mast cell tumours: From laboratory to clinic.

  2015cites this paper
• Etiologier till mastocytom hos hund

  2015influential citation
• C-kit as a prognostic and therapeutic marker in canine cutaneous mast cell tumours: From laboratory to clinic.

  2015cites this paper